In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma—relationship to DNA content

[1]  K. Sugimachi,et al.  Evaluation of extensive lymph node dissection for carcinoma of the stomach , 1981, World Journal of Surgery.

[2]  M. Rugge,et al.  Advanced gastric cancer and prognosis , 2004, Virchows Archiv A.

[3]  M. Morita,et al.  Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus. , 1990, Surgery, gynecology & obstetrics.

[4]  Y. Maehara,et al.  Estrogen-receptor-negative breast cancer tissue is chemosensitive in vitro compared with estrogen-receptor-positive tissue. , 1990, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[5]  K. Sugimachi,et al.  Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses. , 1989, Archives of surgery.

[6]  K. Sugimachi,et al.  Dna ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer , 1988 .

[7]  D. Dent,et al.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma , 1988, The British journal of surgery.

[8]  K. Sugimachi,et al.  Results of resection of gastric cancer extending to adjacent organs , 1988, The British journal of surgery.

[9]  K. Sugimachi,et al.  DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer. , 1988, Cancer.

[10]  T. Hattori,et al.  Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation. , 1987, Cancer research.

[11]  Y. Maehara,et al.  Comparison of the chemosensitivity of human neoplastic tissues between succinate dehydrogenase inhibition test and ATP assay. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[12]  K. Sugimachi,et al.  Accurate prognostic value of morphovolumetric analysis of advanced carcinoma of the stomach. , 1987, Surgery, gynecology & obstetrics.

[13]  Y. Maehara,et al.  The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability. , 1987, European journal of cancer & clinical oncology.

[14]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[15]  Y. Maehara,et al.  Comparison between succinate dehydrogenase inhibition test and subrenal capsule assay for chemosensitivity testing. , 1987, Oncology.

[16]  Y. Maehara,et al.  Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma. , 1987, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  D. Korenaga,et al.  DNA ploidy in clinical malignant gastric lesions less than 5 mm in diameter , 1986, Cancer.

[18]  Y. Maehara,et al.  Partial hepatectomy alters sensitivity of rat hepatocytes to 5-fluorouracil. , 1986, Cancer letters.

[19]  P. O’Brien,et al.  Soft agarose culture human tumour colony forming assay for drug sensitivity testing: [3H]-thymidine incorporation vs colony counting. , 1985, British Journal of Cancer.

[20]  Lippman Me,et al.  Clonogenic and nonclonogenic in vitro chemosensitivity assays , 1985 .

[21]  L. Weisenthal,et al.  Clonogenic and nonclonogenic in vitro chemosensitivity assays. , 1985, Cancer treatment reports.

[22]  V. Sondak,et al.  Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations , 1984, Cancer.

[23]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[24]  A. Bogdén,et al.  Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy , 1983, Cancer.

[25]  J. Kovach,et al.  A Phase I study of the combination N‐(phosphonacetyl)‐L‐aspartate (PALA, NSC‐224131) and L‐alanosine (NSC‐153353) in patients with advanced cancer , 1983, Cancer.

[26]  T. Okamura,et al.  Differentiation of growth patterns of early gastric carcinoma determined by cytophotometric0 DNA analysis , 1983, Cancer.

[27]  L. Bizer.  Adenocarcinoma of the stomach: Current results of treatment , 1983, Cancer.

[28]  Y. Kato,et al.  Pathological studies of human gastric cancer. , 1982, Acta pathologica japonica.

[29]  Shiu Mh,et al.  Management by en bloc multiple organ resection of carcinoma of the stomach invading adjacent organs. , 1981 .

[30]  G. Steel,et al.  Growth kinetics of tumours : cell population kinetics in relation to the growth and treatment of cancer , 1977 .

[31]  S. Kim,et al.  Lethal effect of adriamycin on the division cycle of HeLa cells. , 1972, Cancer research.

[32]  T. Kondo.  Prediction of response of tumor and host to cancer chemotherapy. , 1971, National Cancer Institute monograph.

[33]  H. Ichihashi,et al.  In vitro test for sensitivity of tumor to carcinostatic agents. , 1966, Gan.

[34]  M. Mendelsohn.  The two-wavelength method of microspectrophotometry. II. A set of tables to facilitate the calculations. , 1958 .

[35]  H. Naora,et al.  Microspectrophotometry of cell nucleus stained by feulgen reaction. I. Microspectrophotometric apparatus without Schwarzschild-Villiger effect. , 1955, Experimental cell research.